Arrow QVM Equity Factor ETF
QVM
New York Stock Exchange Arca- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Arrow QVM Equity Factor ETF (QVM) is an exchange-traded fund that seeks to replicate, before fees and expenses, the price and yield performance of the Arrow Investment Insights Quality Value Momentum (AIQVM) Index. The fund invests in an equally weighted portfolio of approximately 50 U.S.-listed large-, mid- and small-cap stocks selected through a proprietary Tri-Factor screening process developed in collaboration with Ford Equity Research, which evaluates securities based on combined quality, value and momentum factors to provide equity market exposure with reduced volatility. The AIQVM Index emphasizes quality metrics for downside protection, value for attractive valuations and momentum for upside capture; the ETF trades on the NYSE under the ticker QVM with an expense ratio of 0.65%. Issued by Arrow Investments Trust and managed under the ArrowShares brand by Arrow Investment Advisors, LLC, the fund targets investors seeking smart beta equity strategies blending multiple factors; it primarily serves individual and institutional investors through brokerage platforms with a focus on U.S. domestic equities. Headquartered in Laurel, Maryland, Arrow Investment Advisors, the sponsor affiliated with Arrow Funds, launched the ETF in March 2015 as its first self-indexed product alongside offerings like the Arrow Dow Jones Global Yield ETF. In a significant operational change, Arrow Funds announced the closure and liquidation of the QVM ETF on November 2, 2020, due to insufficient market demand, with the fund ceasing operations and distributing assets to shareholders on November 16, 2020; the ETF is no longer active and trading. Prior to closure, the fund exhibited high concentration in its top holdings, with the top 10 positions comprising over 90% of assets, primarily in technology, healthcare and industrials sectors. No recent partnerships, funding rounds or relaunches have been reported as of 2025.